[January 10, 2013]

Research and Markets: Neuropathic Pain Report - Analysis of the $5.7 Billion Market

Research and Markets (http://www.researchandmarkets.com/research/shgwjg/neuropathic_pain) has announced the addition of Decision Resources, Inc's new report "Neuropathic Pain" to their offering.

Neuropathic pain (NP) is a prominent form of pain associated with a wide variety of common diseases and conditions, including cancer, diabetes, herpes zoster, chronic back pai, stroke, and multiple sclerosis. In 2010, sales for neuropathic pain therapies in the major pharmaceutical markets under study totaled nearly $5.7 billion. The large patient population, significant percentage of patients refractory to treatment, high rate of polypharmacy, and large unmet need combine to make the NP market one of significant opportunity for drug developers.

Key Topics Covered:

1 Etiology and Pathophysiology

2 Key Neuropathic Pain Populations

3 Current Therapies and Medical Practice

4 Unmet Needs

5 Emerging Therapies

6 Market Outlook

For more information visit http://www.researchandmarkets.com/research/shgwjg/neuropathic_pain

Source (News - Alert): Decision Resources, Inc

[ Back To Technology News's Homepage ]